Toma Biosciences

company

About

Toma Biosciences is a biotechnology company that develops and provides DNA-based cancer testing technology.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$3.60M
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Close

TOMA Biosciences is a genomics company that provides physicians with information to optimize treatment for cancer patients. TOMA’s proprietary sequencing solution turns the latest next=generation sequencing (NGS) technology into a powerful digital tool to detect the most clinically meaningful changes in a patient’s tumor DNA. Physicians use this important data to optimize treatment for their patients.

TOMA technology enables laboratories to uncover the DNA alterations in cancer cells to provide meaningful data for researchers and clinicians seeking the optimal treatment options for their patients. The company is a commercial-stage private venture-backed company headquartered in Foster City, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$3.60M
Toma Biosciences has raised a total of $3.60M in funding over 2 rounds. Their latest funding was raised on Feb 1, 2019 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2019 Series Unknown $7.80K 1 Detail
Jul 21, 2018 Series C $3.60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Toma Biosciences is funded by 2 investors. Keiretsu Forum and SAYJ Global Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Keiretsu Forum Series Unknown
SAYJ Global Partners Series C